Factor IXa was shown to inactivate both factor Vlll and factor Vllla in a phospholipid-dependent reaction that could be blocked by an antifactor IX antibody. Factor IXa-catalyzed inactivation correlated with proteolytic cleavages within the A1 subunit of factor Vllla and within the heavy chain (contiguous AI-A2-6 domains) of factor VIII. Furthermore, a relatively slow conversion of factor Vlll light chain to a 68-Kd fragment was observed after prolonged incubation. Sites of cleavage were identified within the A1 domain at Arg336-Met337 and within the factor Vlll light chain at Arg1719-Asn1720. Factor IXa failed to cleave isolated factor Vlll heavy chains, yet cleaved isolated factor Vlll light chain. In addition, ACTOR VI11 is a plasma glycoprotein critical to F hemostasis, because its deficiency results in the most common of the severe bleeding disorders, hemophilia A. Factor VI11 is synthesized as a single chain precursor of domain structure Al-A2-B-A3-Cl-C2.' Cleavage at the B-A3 junction, coupled with limited cleavages within the B domain, result in the circulating Me2+-linked heterodimeric Factor VI11 contains a variable-sized heavy chain, minimally represented by the A1-A2 domains, but often possessing portions of the B domain, and a light chain represented by the A3-Cl-C2 domains. Conversion of factor VI11 to its active form, factor VIIIa, allows its participation as a cofactor in the factor IXa-mediated proteolytic conversion of factor X to Xa.5
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0 1992 by The American Society of Hematology. 0006-4971 /92/8012-0023$3.00/0 the purified AI/A3-Cl-C2 dimer derived from factor Vllla was a substrate for factor IXa; however, cleavage of the A I subunit occurred at less than 30% the rate of cleavage of A I in trimeric factor Vllla. These data suggest that factor Vlll light chain contributes to the binding site for factor IXa and also support a role for a heavy chain determinant located within the A2 subunit in the association of factor Vllla with factor IXa. Furthermore, the capacity of factor IXa to proteolytically inactivate its cofactor, factor Vllla, suggests a mode of regulation within the intrinsic tenase complex. 0 1992 by The American Society of Hematology.
activity occurs spontaneously without further proteolysis owing to pH-dependent dissociation of the A2 subunit from a stable but inactive Al/A3-Cl-C2 dimer. 9 Factor Xa has been reported to activate factor VIII,6t7J1 yielding the same cleavage fragments as those generated by thrombin. Subsequent inactivation correlates with further cleavage of factor VIIIa.7 Factor IXa has also been implicated in activation of factor VII112,13; however, the extent of activation is reduced compared with either thrombin or factor Xa. Factor VIII(a) is proteolytically inactivated by the potent anticoagulant activated protein C.11,14,15 The sites of protease cleavage within factor VIII(a) occur at residues 562, which bisects the A2 domain, and within the A1 domain at residue 336.16
Previously, we observed that reconstituted factor VIIIa was transiently stabilized by factor IXa and subsequent loss of cofactor activity appeared to correlate with prote01ysis.l~ In this report, we further characterize the proteolytic interaction between factor IXa-and factor VIII-derived substrates with respect to cofactor activity and covalent alteration. Additionally, the use of several factor VIIIderived substrates adds insight into interactions between factor VIII(a) and factor IXa.
VIII-derived substrates, by factor IXa was performed in buffer A (0.02 mol/L HEPES, pH 7.2,0.15 mol/L NaCI, 0.005 mol/L CaC12, and 0.01% Tween 20) . Factor IXa (650 nM) was preincubated with hirudin (50 U/mL) for 30 minutes prior to combining with factor VIII-derived substrates to inhibit any potential thrombin contamination. All reactions were run at 22°C and contained phospholipid in the form of inosithin at concentrations noted in the figure legends. Samples were removed at indicated times and assayed for factor VI11 activity, or they were analyzed by reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by either silver staining or Western blotting. Under the reaction conditions used, factor IXa had no effect on the plasmabased assay for factor VIIIa activity. The effect of the antifactor IX antibody on inactivation of factor VI11 was performed by preincubating factor IXa (650 nmol/L) either in the presence or absence of antibody (119 pg/mL) for 60 minutes at 22°C before combining with factor VIII. Thrombin activation of factor VI11 was performed in buffer A containing 225 mmol/L NaCI. Factor VI11 (66 pg/mL) was incubated with thrombin (1 pg/mL) at 22°C. Assuming an average molecular weight of 220,000 for factor VIW9 and 36,600 for thrombin,2O this represents approximately 1:11 molar ratio of thrombin to factor VI11 in the reaction. Under these conditions, factor VIIIa activity was maximal by 2 minutes. At 10 minutes, the factor VIIIa was added to reactions for subsequent inactivation by factor IXa. These reactions contained hirudin (1 to 5 U/mL) to inhibit thrombin activity. Protein concentration was determined by the Coomassie dye binding method of Bradford?
SDS-PAGE was performed using the Laemmli buffer system2* and a Bio-Rad (Richmond, CA) minigel electrophoresis system. Electrophoresis was for 1 hour at 150 V, and protein bands were visualized after either staining with silver nitrateU or Western blotting. For the latter analysis, unstained gels were transferred to polyvinylidene difluoride (PVDF) membrane using the procedure of Matsudaira.x Bands on the membranes that reacted to the R8B12 antibody were visualized as described previously.16 Densitometric scans were performed using an LKB Ultrascan Laser densitometer with peak integrator (Piscataway, NJ).
NHz-terminal sequence analysis of electrophoretically resolved factor V7ZZ polypeptides. Factor VI11 (260 pg/mL, 0.14 mL) was reacted with factor IXa (5.6 pg/mL) in buffer A containing 400 pg/mL phospholipid at 22°C until less than 5% of the initial factor VI11 activity remained. The reaction was subjected to SDS-PAGE using a 10% separating gel. After electrophoresis, the resolved fragments were transferred to PVDF membrane that was then briefly stained with Coomassie blue." Bands corresponding to the -68-, -48-, and -45-Kd fragments were excised and subjected to 10 cycles of automated amino-terminal sequence analysis using an Applied Biosystems' pulsed-liquid phase sequenator (model 477A, Foster City, CA).
Electrophoresis.

RESULTS
Heterodimeric
factor VI11 was treated with varying levels of factor IXa in a reaction containing calcium in the presence or absence of phospholipid (Fig 1) . In the absence of phospholipid, no change in factor VI11 activity was detected at a 1:l molar ratio of factor IXa to factor VIII. In the presence of phospholipid, a loss of cofactor activity was observed, with the rate of inactivation dependent on factor IXa concentration. At lower factor IXa concentrations, a lag was observed before inactivation (data not shown). Factor IXa used for these and subsequent reactions was preincubated with Inactivation of factor U Z Z by factor ZXa. hirudin to inhibit any possible trace levels of thrombin in the factor IXa preparation. To further confirm that the inactivation was due to factor IXa and not a contaminating protease, factor IXa was preincubated with an antifactor IX polyclonal antibody before reaction with factor VIII. Inactivation was blocked after preincubation of factor IXa with the antibody (Fig 2) . Therefore, the inactivation of factor VI11 appeared specific for factor IXa.
A reaction time course of inactivation of factor VIII by factor IXa in the presence of phospholipid was analyzed by . At the times indicated, aliquots were removed and a portion assayed for factor Vlll activity. The remainder of the sample was subjected t o SDS-PAGE using an 8% gel, and bands were visualized by silver staining. HC and LC designate the positions of factor Vlll heavy and light chains, respectively. Arrows indicate the positions of the major cleavage products.
SDS-PAGE followed by silver staining, with the results shown in Fig 3. Inactivation was rapid, with cleavages observed within both factor VIII heavy and light chains. Initial cleavages resulted in conversion of heavy chains to smaller-sized fragments. Most notable were the conversion of the -210-Kd species to a -170-Kd fragment, and the concomitant appearance of two lower molecular weight fragments of -45 and -48 Kd. Assuming equivalcnt staining characteristics for the low molecular weight fragments, the -45-Kd fragment was the relatively more abundant cleavage product. Disappearance of heavy chains and appearance of the -45-and -48-Kd fragments correlate with cofactor inactivation. By 1 hour, an additional band at -43 Kd appears and increases as the -48-Kd band decreases, suggesting this fragment may be produced from additional clcavage within the 48-Kd peptide. A doublet fragment of -68/66 Kd was also generated, concomitant with thc disappearance of the factor VIII light chain doublet. This fragment was slightly smaller than the light chain-derived A3-Cl-C2 fragment obtained from thrombin cleavage of factor VIII. Thc -43-and -68-Kd bands appeared subsequent to factor VIII inactivation.
Reactivity of the factor IXa-generated factor VIII fragments to a monoclonal antibody, R8B12, was tested. This antibody, which recognizes a COOH-terminal cpitope located within the A2 domain of factor VIII heavy chain,"J6 reacted with factor VI11 heavy chains and the -170-and -48-Kd fragments, suggesting these fragments contain this epitope (Fig 4) . In addition, faint bands of -83 and -67 Kd also reacted with this antibody. These bands did not represent cross-reactivity to factor VIII light chain and light chain cleavage product, respectively, because no reactivity to light chain in the control lane was detected. Therefore, thcsc bands likely represent COOH-terminal heavy chainderived cleavage products from the 110-and 120-Kd heavy chain species that were likely obscured in the silver stained gel by the presence of light chain and light chain cleavage product. The -43-Kd fragment produccd after prolonged incubation of factor VIII with factor IXa also reacted to the R8B12 antibody (data not shown), further suggesting that this fragment results from additional cleavage within the 48-Kd fragment.
A concentrated sample of factor VIII (1.18 pmol/L) was reacted with factor IXa (0.13 pmol/L) under similar reaction conditions as described above, except phospholipid concentration was elevated to 400 pg/mL. Factor VIII activity was monitored by clotting assay, and the reaction was terminated when less than 5% of the original activity remained. Fragments from the digest were resolved after SDS-PAGE, transferred to PVDF membranes, and stained with Coomassic blue, as described in Materials and Methods. Identification of the -48-Kd fragment was further confirmed through Western blotting of a gel sample run in parallel by reaction to the R8B12 monoclonal antibody. Excised bands were subjected to 10 cycles of automated amino-terminal sequence analysis, and the results are shown in Table 1 .
The results indicate that the -45-Kd fragment was Amino-terminal sequence analjsis. derived from the NHz-terminus of the heavy chains. The apparent size of this fragment was consistent with cleavage at Arg336-Mct337. Cleavage at this sitc by factor IXa was confirmed by NH2-teminal sequence analysisof t he -48-Kd fragment that initiated at Met337 and most likely originated from the carboy-terminus of the -90-Kd heavy chain species. The relative low abundance of this product as compared to fragment AI suggests that it did not originate from all heavy chains species, and therefore further suggests that factor IXa docs not eRicicntly cleave the A2-B
LC -
domainal junction region of factor VI11 at Arg740-Scr741, a sitc rapidly cleaved by thrombin,' and proposed for activated protein C,'" and factor Xa? A second protease site, located at Argl719-A.nl720, converts factor VIII light chain to the -68-Kd fragment.
To determine if proteolysis of factor VI11 requires intact hctcrodimeric factor VIII. isolated factor VI11 light chain or heavy chain subunits were evaluated as substrates for factor IXa (Fig 5) . Factor IXa catalyzed slow cleavage of light chain, yielding the -6 8 / 6 K d fragment observcd in rcactions with intact factor VI11 and confirmed the light chain origin for this fragment. No cleavage of isolated heavy chains was detected (data not shown), suggesting a light chain requirement for proteolysis of this component. Thcsc data suggest that a portion of the binding sitc for factor IXa is locatcd on factor VI11 light chain, because factor IXa can bind and cleave light chain in the absence of heavy chains.
To assess the contribution of the factor VI11 light chain in the binding of the protease, factor IXa inactivation of factor VI11 was performed either in the absence or presence of a seven-fold molar ~X C~S S of factor VI11 light chain over factor VI11 heterodimer. If light chain compctes with factor VI11 for binding to factor IXa, then a reduccd rate of factor VIII inactivation should occur. However, under these conditions, no change in the rate of factor VI11 inactivation was observed (Fig 6) . This suggests that the binding of factor IXa with factor VI11 light chain is weak relative to association with intact heterodimer and that factor VI11 heavy chain plays an important role in binding factor IXa.
Factor IXa cleavage of factor VIUa and AIlA3-CI-C2. Because it is the activated form of factor VIII, factor VIIIa, that scrves as a cofactor for factor IXa, analysis of the proteolytic activity toward factor Vllla substrates was performed. Thrombin-activated factor VIIIa was combined with factor IXa in a reaction containing calcium and phospholipid (Fig 7) . A rapid decay of cofactor activity was detected that correlated with proteolysis of the A1 subunit and the appearance of the -45-Kd fragment that migrated just above the A2 subunit, presumably thc result ofclcavage at Arg336-Mct337. The rate of loss of AI subunit, as judgcd by laser densitometric scans of the gel, paralleled the ratc of decay of factor VIlIa activity (data not shown). This result confirmed our earlier observation of factor IXa inactivation of reconstituted factor VIIIa.I7 Although no additional change in the mobility of factor Vllla subunits was apparent, the A2 subunit appcared to migratc as a less distinct band after prolonged rcaction with factor IXa. The apparent lack ofcleavage of the factor Vllla A3-Cl-CZ subunit at the Arg1719-Am1720 site likely reflects the short time course and reduced enzyme to substrate ratio used in this experiment compared with the reaction conditions showing clcavagc of the factor VI11 light chain (Fig 3) . Isolated Al/A?-Cl-C2 dimcrwas also used as a substrate for the proteasc with cleavage of the AI subunit to the 45-Kd fragment (Fig 7) . Because the same site appcarcd to be cleaved in factor Vllla and the Al/k?-Cl-C2 dimer, the relative rates of cleavage of the A1 subunit in the two factor IXa substrates were compared. Figure 8 illustrates the relative rates of disappcarance of thc A1 subunit in these reactions as determined by densitometry scans of the stained gels. The initial rate of cleavage of AI in the heterotrimer was grcatcr than threefold faster than that observed for the Al/A?-CI-C2 dimer. This result suggests that, although the A2 subunit is not csscntial for factor IXa association with factor Vllla and subsequent cleavage of the A1 subunit, it may enhance the interaction of protease with substrate.
DISCUSSION
Recently, we reported that factor IXa slowly inactivated factor VIlla that had been reconstituted from isolatcd Al/A3-Cl-C2 dimer and A2 suhunit.I7 In this study we have further investigated the interactions of factor IXa with factor Vlll(a) by examining the protcolytic activity of factor IXa toward several factor VIII-derivcd substrates. Roth factor VI11 and factor Vllla were inactivated by factor IXa. Inactivation of factor Vlll was depcndcnt on phospholipid and spccific for factor IXa, because it was blocked by antifactor IX antibody.
Our rcsults suggcst no activation of factor VI11 by factor IXa. This is in contrast to the work of Rick,Iz who showed that factor IXa catalyzed a modest (2-to &fold) activation of factor VIII. Thc cffcct rcquircd relatively high ratios of factor IXa to factor VI11 and was indcpendcnt of the presence of phospholipid. Ncuenschwandcr and Jesty rcported factor IXa activated factor VI11 at a slow rate, as measured by the potentiation of acetylated factor X activation.I3 Our experiments do not rule out the possibility that factor VI11 fragments produced by factor IXa possess transicnt cofactor activity. However, studies dcscribcd in this rcport indicate that thc major proteolytic cffcct of factor IXa on factor Vlll(a) correlates with inactivation.
Factor IXa inactivated factor VI11 (and factor Vllla) via cleavage at residue 336. resulting in the appcarancc of a -45-Kd fragmcnt, originating from factor VI11 heavy chain NHz-tcrminus. and a scries of fragments ranging from -48 to -170 Kd, derived from thc COOH-tcrmini of thc heterogeneous heavy chains. These conclusions are supported by the following evidence. For Very recently, a report by O'Brien et a125 was published on the interaction of factor IXa with factor VIII. These investigators also observed no activation of factor VI11 by factor IXa, and they described inactivation of factor VI11 correlating with cleavage of factor VI11 heavy chains and production of the -45-Kd cleavage product. In addition, they observed lagging cleavage within the light chain at Arg1719-Asn1720. However, they did not detect the heavy chain-derived -48-Kd cleavage product and, therefore, postulated that the inactivating cleavage had occurred at Arg336-Met337. Their inability to detect the -48-Kd fragment may have resulted from low levels of the -90-Kd heavy chains species in their factor VI11 preparation, thereby limiting the potential yield of the -48-Kd fragment. Our results define a cleavage site at Arg336-Met337 by NHz-terminal sequence analysis of this fragment and support the hypothesis that this cleavage is inactivating.
Several interactions between factor IXa and factor VIII(a) were illustrated through examination of factor IXa cleavage of various factor VIII-derived substrates. The proteolytic interactions take place on a phospholipid surface. This is supported by the phospholipid requirement for inactivation and the fact that isolated factor VI11 heavy chains, which do not contain the factor VI11 lipid binding region,% were not substrates for factor IXa. Second, factor IXa was able to bind isolated factor VI11 light chain, because light chain cleavage occurred in the absence of factor VI11 heavy chains. However, this interaction is likely of lower affinity compared with the factor IXa-factor VI11 heterodimer interaction, because inactivation of factor VI11 was not inhibited by a sevenfold molar excess of factor VI11 light chain. This result also suggests a heavy chain contribution to the factor IXa-VIII(a) interaction. Comparison of the rate of A1 cleavage in factor VIIIa heterotrimer and in the Al/A3-Cl-C2 dimer in reactions performed under the same reaction conditions indicated that the presence of A2 accelerated the rate of A1 cleavage severalfold. This result suggested that the A2 subunit plays a role in association of factor IXa with factor VIII(a) either by providing a determinant for factor IXa binding or by altering the factor IXa-dimer association. This is in agreement with our earlier work," which showed the maximum change in fluorescence polarization of the dansylated active sitelabeled factor IXa, DEGR-IXa, occurred in the presence of all three subunits of factor VIIIa, as compared with values in the presence of either isolated A2 subunit or Al/A3-Cl-C2 dimer. A multisubunit requirement for proteasecofactor interaction is also observed in the analogous prothrombinase complex, where both factor Va light and heavy chains are necessary for binding to factor Xa.27 Both thrombin and factor Xa possess the ability to generate cleavage at residues 372, 740, and 1689 to produce fragments of 43 (A2), 50 (Al) , and 73 Kd (A3-Cl-C2). However, the relatively limited activation by factor Xa correlates with additional cleavage at Arg336-Met337, a site shared by the inactivating proteases-activated protein C,16 and factor IXa (this report). Thus, the cleavage site at residue 336 is a common target for inactivation of factor VIII(a). The mechanism of inactivation following cleavage at this site is not known; however, a possible role would be to weaken the interaction of the A2 subunit with the A1 /A3-Cl-C2 dimer. This hypothesis has been proposed earlier based upon results from our laboratory indicating the failure of the truncated A1336/A3-C1-C2 dimer, generated by activated protein C cleavage, to bind A2 subunit.16 This reduced affinity of A2 with dimer could subsequently affect the factor IXa-factor VIIIa complex, because the dimer in the absence of A2 appears to have a limited interaction with factor IXa17 (this report). Factor IXa and factor Xa also cleave factor VI11 near the NHz-terminus of the light chain, at Argl719-As111720~~ (this report) and Arg1721-Asp1722,7 respectively. Factor IXa-catalyzed light chain cleavage lags behind cleavage at residue 336, whereas rates of cleavage at these sites are equivalent with factor Xa.7 Thus, the role of light chain cleavage is not known.
Earlier reports indicated that low concentrations of porcine factor VIIIa were stabilized by the presence of factor IXa and p h o~p h o l i p i d .~,~~ More recently, we reported that factor IXa transiently stabilized human factor VIIIa reconstituted from isolated subunits. 17 In that study, the subsequent loss of cofactor activity correlated with proteolysis, whereas a more prolonged enhancement of reconstituted cofactor activity required active site-inhibited factor IXa. The apparent disparity of these observations suggesting a stabilizing role for factor IXa with the data of this report and O'Brien et alz5 indicating an inactivating role for factor IXa may result from the concentrations of components used in these studies, perhaps most important being the cofactor concentration. Factor VIIIa is markedly labile and spontaneous inactivation correlates with dissociation of the A2 subunit from the Al/A3-Cl-C2 dimer? In the human protein, this interaction is reversible with a kd of -30 nmol/L at pH 6.0 and -260 nmol/L at pH 7.4.3O The factor IXa-factor VIIIa interaction is a higher affinity one with a kd of -6 n m~l / L .~l Based upon data from Fig 8, the rate of factor IXa cleavage of factor VIIIa is approximately 0.3 nmol factor VIIIa cleaved per minute per nmol factor IXa. Thus, if the rate of cleavage is slow relative to the association rate constant for factor IXa-factor VIIIa interaction and the dissociation rate constant for the A2-dimer For personal use only. on October 22, 2017. by guest www.bloodjournal.org From interaction, then factor IXa interaction with low concentrations of factor VIIIa, as observed in the earlier porcine studies ( -1 nmol/L components**) and in the partially reconstituted human heterotrimers, could in fact be stabilizing relative to the spontaneous dissociation of A2 subunit at these concentrations. On the other hand, reaction of factor IXa with significantly higher concentrations of factor VIIIa in the latter studies, where much of the material exists as heterotrimer, could be observed as solely inactivating as a result of slow cleavage of the A1 subunit. The role for factor IXa inactivation of factor VIII(a) is unknown but may serve to regulate factor VIIIa activity during factor X generation by the intrinsic tenase complex. Self-damping of the activation of factor X by factors IXa and VIIIa has been previously and proteolytic inactivation of factor VIIIa by factor IXa may contribute to this effect. Further study is also necessary to evaluate the importance of this mode of regulation relative to other anticoagulant pathways such as the protein C system.
